RNCRR uses Parascript' AccuDetect CAD software to detect breast cancer

Parascript, LLC, the image analysis and pattern recognition solution provider, today announced the use of its AccuDetect computer aided detection (CAD) software by the Russian Center for Roentgeno - Radiology Research (RNCRR) in Moscow. RNCRR is Russia's largest, most recognized breast cancer oncology center.

Breast cancer is the most common form of cancer in women in Russia and is the leading cause of cancer mortality. Only 60 percent of breast cancer is diagnosed at an early or localized stage.  Parascript AccuDetect is designed to contribute to better cancer detection and lower patient recalls through employment of complementary algorithms and two major, proprietary technology approaches.  The first approach detects the presence of suspicious lesions on mammogram images. The second utilizes sophisticated voting methods to combine the results from each algorithm to produce the highest sensitivity and lowest false-positive rates.

"As a premier medical institution specializing in early diagnostic and treatment of oncology diseases, RNCRR is dedicated to offering the most advanced technology to detect breast cancer earlier," said Dr. Nadezha I. Rozhkova, professor of oncology at RNCRR. "Parascript AccuDetect is an invaluable addition to our center that will benefit patients from all over Russia."  

More than 1,400 mammography acquisition stations are currently in use in Russia from manufacturers such as FujiFilm, General Electric, IMS and Siemens, among others. RNCRR utilizes modern mammography acquisition stations, including FujiFilm FCR Profect CS and GE Senographe Essential, in its Moscow facilities.  

"We look forward to continued adoption of our CAD solution in Russia and to a strong partnership with the renowned RNCRR," said Yuri Prizemin, director of product marketing for Parascript. "We are committed to applying our image analysis technology to help radiologists detect breast cancers earlier and with lower false-positive rates."